First Estradiol-based Oral Contraceptive Qlaira® Cleared For Market Launch In Europe
Bayer Schering Pharma AG has successfully completed the decentralized drug approval procedure in Europe for its new oral contraceptive Qlaira® (dienogest/estradiol valerate). Qlaira® is an oral contraceptive whose estrogen component is based on estradiol, the same estrogen that is produced by the female body.
More: continued here
Filed under: Fertility on October 26th, 2008